Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 269

    1.

    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease.

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; the TREAT Investigators.

    N Engl J Med. 2009 Nov 19;361(21):2019-2032. Epub 2009 Oct 30.PMID: 19880844 [PubMed - as supplied by publisher]Related articles

    2.

    Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.

    Kopciuk KA, Choi YH, Parkhomenko E, Parfrey P, McLaughlin J, Green J, Briollais L.

    Hered Cancer Clin Pract. 2009 Oct 28;7(1):16.PMID: 19863818 [PubMed - in process]Related articlesFree article

    3.

    Mechanisms of the cardiorenal syndromes.

    Shamseddin MK, Parfrey PS.

    Nat Rev Nephrol. 2009 Nov;5(11):641-9. Epub 2009 Sep 29.PMID: 19786991 [PubMed - in process]Related articles

    4.

    Angiotensin-receptor blockers in the prevention or treatment of microalbuminuria.

    Parfrey PS.

    Ann Intern Med. 2009 Jul 7;151(1):63-5. No abstract available. PMID: 19581647 [PubMed - indexed for MEDLINE]Related articles

    5.

    The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.

    O'Reilly DJ, Goeree RA, Tarride JE, James C, Parfrey PS.

    Can J Clin Pharmacol. 2009 Summer;16(2):e346-59. Epub 2009 Jun 16.PMID: 19531813 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

    Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill J, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Uno H; TREAT Investigators.

    Am J Kidney Dis. 2009 Jul;54(1):59-69. Epub 2009 Jun 5.PMID: 19501439 [PubMed - indexed for MEDLINE]Related articles

    7.

    Variable neurologic phenotype in a GEFS+ family with a novel mutation in SCN1A.

    Mahoney K, Moore SJ, Buckley D, Alam M, Parfrey P, Penney S, Merner N, Hodgkinson K, Young TL.

    Seizure. 2009 Sep;18(7):492-7. Epub 2009 May 21.PMID: 19464195 [PubMed - indexed for MEDLINE]Related articles

    8.

    Family history of renal disease severity predicts the mutated gene in ADPKD.

    Barua M, Cil O, Paterson AD, Wang K, He N, Dicks E, Parfrey P, Pei Y.

    J Am Soc Nephrol. 2009 Aug;20(8):1833-8. Epub 2009 May 14.PMID: 19443633 [PubMed - indexed for MEDLINE]Related articles

    9.

    Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces.

    Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG.

    Can J Surg. 2009 Apr;52(2):92-7.PMID: 19399202 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Autosomal recessive Bardet-Biedl syndrome: first-degree relatives have no predisposition to metabolic and renal disorders.

    Webb MP, Dicks EL, Green JS, Moore SJ, Warden GM, Gamberg JS, Davidson WS, Young TL, Parfrey PS.

    Kidney Int. 2009 Jul;76(2):215-23. Epub 2009 Apr 15.PMID: 19367329 [PubMed - indexed for MEDLINE]Related articles

    11.

    Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis.

    Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P.

    Clin J Am Soc Nephrol. 2009 Apr;4(4):755-62. Epub 2009 Apr 1. Review.PMID: 19339417 [PubMed - indexed for MEDLINE]Related articles

    12.

    Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial.

    Foley RN, Curtis BM, Parfrey PS.

    Clin J Am Soc Nephrol. 2009 Apr;4(4):726-33. Epub 2009 Apr 1.PMID: 19339412 [PubMed - indexed for MEDLINE]Related articles

    13.

    Validity of random-digit-dialing in recruiting controls in a case-control study.

    Wang PP, Dicks E, Gong X, Buehler S, Zhao J, Squires J, Younghusband B, McLaughlin JR, Parfrey PS.

    Am J Health Behav. 2009 Sep-Oct;33(5):513-20.PMID: 19296741 [PubMed - indexed for MEDLINE]Related articles

    14.

    Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study.

    Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, Parfrey P, Potter J, Younghusband B, Gallinger S.

    Gastroenterology. 2009 Apr;136(4):1251-60. Epub 2008 Dec 27.PMID: 19245865 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prediction of Lynch syndrome in consecutive patients with colorectal cancer.

    Green RC, Parfrey PS, Woods MO, Younghusband HB.

    J Natl Cancer Inst. 2009 Mar 4;101(5):331-40. Epub 2009 Feb 24.PMID: 19244167 [PubMed - indexed for MEDLINE]Related articles

    16.

    Budgeting, funding, and managing clinical research projects.

    Hatfield E, Dicks E, Parfrey P.

    Methods Mol Biol. 2009;473:299-311. Review.PMID: 19160746 [PubMed - indexed for MEDLINE]Related articles

    17.

    Bias in clinical studies of genetic diseases.

    Stuckless S, Parfrey PS.

    Methods Mol Biol. 2009;473:171-86. Review.PMID: 19160738 [PubMed - indexed for MEDLINE]Related articles

    18.

    The design of randomized controlled trials.

    Curtis BM, Barrett BJ, Parfrey PS.

    Methods Mol Biol. 2009;473:95-111. Review.PMID: 19160733 [PubMed - indexed for MEDLINE]Related articles

    19.

    Modeling longitudinal data, II: standard regression models and extensions.

    Ravani P, Barrett B, Parfrey P.

    Methods Mol Biol. 2009;473:61-94. Review.PMID: 19160732 [PubMed - indexed for MEDLINE]Related articles

    20.

    Modeling longitudinal data, I: principles of multivariate analysis.

    Ravani P, Barrett B, Parfrey P.

    Methods Mol Biol. 2009;473:39-60. Review.PMID: 19160731 [PubMed - indexed for MEDLINE]Related articles

    21.

    On framing the research question and choosing the appropriate research design.

    Parfrey P, Ravani P.

    Methods Mol Biol. 2009;473:1-17. Review.PMID: 19160729 [PubMed - indexed for MEDLINE]Related articles

    22.

    Unified criteria for ultrasonographic diagnosis of ADPKD.

    Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D.

    J Am Soc Nephrol. 2009 Jan;20(1):205-12. Epub 2008 Oct 22.PMID: 18945943 [PubMed - indexed for MEDLINE]Related articles

    23.

    Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.

    Foley RN, Curtis BM, Parfrey PS.

    Clin J Am Soc Nephrol. 2008 Nov;3(6):1669-75. Epub 2008 Oct 15.PMID: 18922988 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Planning the restructuring of long-term care: the demand, need and provision of institutional long-term care beds in Newfoundland and Labrador.

    Hughes N, McDonald J, Barrett B, Parfrey P.

    Healthc Manage Forum. 2008 Summer;21(2):6-22. English, French. PMID: 18795554 [PubMed - indexed for MEDLINE]Related articles

    25.

    The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland.

    Moore SJ, Buckley DJ, MacMillan A, Marshall HD, Steele L, Ray PN, Nawaz Z, Baskin B, Frecker M, Carr SM, Ives E, Parfrey PS.

    Clin Genet. 2008 Sep;74(3):213-22. Epub 2008 Aug 4.PMID: 18684116 [PubMed - indexed for MEDLINE]Related articles

    26.

    Clinical research of kidney diseases V: extended analytic models.

    Ravani P, Parfrey P, Gadag V, Malberti F, Barrett B.

    Nephrol Dial Transplant. 2008 May;23(5):1484-92. Review. No abstract available. PMID: 18424464 [PubMed - indexed for MEDLINE]Related articles

    27.

    Clinical research of kidney diseases II: problems of study design.

    Ravani P, Parfrey PS, Dicks E, Barrett BJ.

    Nephrol Dial Transplant. 2008 Apr 9. [Epub ahead of print] No abstract available. PMID: 18400814 [PubMed - as supplied by publisher]Related articles

    28.

    Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.

    Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, Drenckhahn JD, Kupprion C, Ramadanova K, Thierfelder L, McKenna W, Gallagher B, Morris-Larkin L, Bassett AS, Parfrey PS, Young TL.

    Am J Hum Genet. 2008 Apr;82(4):809-21. Epub 2008 Feb 28.PMID: 18313022 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Clinical research of kidney diseases IV: Standard regression models.

    Ravani P, Parfrey P, Murphy S, Gadag V, Barrett B.

    Nephrol Dial Transplant. 2008 Feb;23(2):475-82. Epub 2008 Jan 8. Review. No abstract available. PMID: 18182407 [PubMed - indexed for MEDLINE]Related articles

    30.

    Clinical research of kidney diseases III: principles of regression and modelling.

    Ravani P, Parfrey P, Gadag V, Malberti F, Barrett B.

    Nephrol Dial Transplant. 2007 Dec;22(12):3422-30. Epub 2007 Nov 19. Review. No abstract available. PMID: 18029371 [PubMed - indexed for MEDLINE]Related articles

    31.

    Inhibitors of the renin angiotensin system: proven benefits, unproven safety.

    Parfrey PS.

    Ann Intern Med. 2008 Jan 1;148(1):76-7. Epub 2007 Nov 5. No abstract available. PMID: 17984483 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Clinical research of kidney diseases 1: researchable questions and valid answers.

    Ravani P, Parfrey PS, Curtis B, Barrett BJ.

    Nephrol Dial Transplant. 2007 Dec;22(12):3681-90. No abstract available. PMID: 17984100 [PubMed - indexed for MEDLINE]Related articles

    33.

    MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer.

    Mrkonjic M, Raptis S, Green RC, Monga N, Daftary D, Dicks E, Younghusband HB, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B.

    Carcinogenesis. 2007 Dec;28(12):2575-80. Epub 2007 Oct 17.PMID: 17942459 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Clinical research of kidney diseases II: problems of study design.

    Ravani P, Parfrey PS, Dicks E, Barrett BJ.

    Nephrol Dial Transplant. 2007 Oct;22(10):2785-94. Epub 2007 Sep 22. No abstract available. Erratum in: Nephrol Dial Transplant. 2008 Jul;23(7):2439. PMID: 17890738 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer.

    Campbell PT, Cotterchio M, Dicks E, Parfrey P, Gallinger S, McLaughlin JR.

    Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1735-44.PMID: 17855691 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Clinical research of kidney diseases 1: researchable questions and valid answers.

    Ravani P, Parfrey PS, Curtis B, Barrett BJ.

    Nephrol Dial Transplant. 2007 Sep;22(9):2459-68. No abstract available. Corrected and republished in: Nephrol Dial Transplant. 2007 Dec;22(12):3681-90. PMID: 17724059 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.

    Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS.

    Clin J Am Soc Nephrol. 2006 Jul;1(4):710-7. Epub 2006 Jun 8.PMID: 17699277 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.

    Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P.

    Clin J Am Soc Nephrol. 2007 Sep;2(5):898-905. Epub 2007 Aug 16.PMID: 17702710 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization?

    O'Reilly D, Craig D, Phillips L, Goeree R, Tarride JE, Parfrey P.

    Healthc Policy. 2007 Aug;3(1):58-79.PMID: 19305756 [PubMed - in process]Related articlesFree article

    40.

    The impact of organizational culture on clinical managers' organizational commitment and turnover intentions.

    Way C, Gregory D, Davis J, Baker N, LeFort S, Barrett B, Parfrey P.

    J Nurs Adm. 2007 May;37(5):235-42.PMID: 17479043 [PubMed - indexed for MEDLINE]Related articles

    41.

    Predictors of registered nurses' organizational commitment and intent to stay.

    Gregory DM, Way CY, LeFort S, Barrett BJ, Parfrey PS.

    Health Care Manage Rev. 2007 Apr-Jun;32(2):119-27.PMID: 17438395 [PubMed - indexed for MEDLINE]Related articles

    42.

    MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.

    Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B.

    J Natl Cancer Inst. 2007 Mar 21;99(6):463-74.PMID: 17374836 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    In the literature: on clinical performance measures and outcomes among hemodialysis patients.

    Parfrey PS.

    Am J Kidney Dis. 2007 Mar;49(3):352-5. No abstract available. PMID: 17336695 [PubMed - indexed for MEDLINE]Related articles

    44.

    The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.

    Stuckless S, Parfrey PS, Woods MO, Cox J, Fitzgerald GW, Green JS, Green RC.

    Fam Cancer. 2007;6(1):1-12.PMID: 17039271 [PubMed - indexed for MEDLINE]Related articles

    45.

    Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies.

    Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB.

    Fam Cancer. 2007;6(1):53-62.PMID: 17039269 [PubMed - indexed for MEDLINE]Related articles

    46.

    Therapy insight: management of cardiovascular disease in the renal transplant recipient.

    Rigatto C, Parfrey P.

    Nat Clin Pract Nephrol. 2006 Sep;2(9):514-26. Review.PMID: 16941044 [PubMed - indexed for MEDLINE]Related articles

    47.

    Clinical practice. Preventing nephropathy induced by contrast medium.

    Barrett BJ, Parfrey PS.

    N Engl J Med. 2006 Jan 26;354(4):379-86. Review. No abstract available. PMID: 16436769 [PubMed - indexed for MEDLINE]Related articles

    48.

    The clinical epidemiology of contrast-induced nephropathy.

    Parfrey P.

    Cardiovasc Intervent Radiol. 2005;28 Suppl 2:S3-11. Review.PMID: 16419277 [PubMed - indexed for MEDLINE]Related articles

    49.

    Target hemoglobin level for EPO therapy in CKD.

    Parfrey PS.

    Am J Kidney Dis. 2006 Jan;47(1):171-3. No abstract available. PMID: 16377399 [PubMed - indexed for MEDLINE]Related articles

    50.

    Long-term care in the St. John's region: impact of single entry and prediction of bed need.

    McDonald J, Hibbs J, Reddy M, Stuckless S, O'Reilly D, Barrett BJ, Parfrey PS.

    Healthc Manage Forum. 2005 Autumn;18(3):6-12, 50-7. English, French. PMID: 16323463 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...